Kulicke & Soffa Industries, Inc. — FY2022 Form 10-K Summary
Reporting period: Fiscal year ended October 1, 2022, compared with fiscal year ended October 2, 2021. The request metadata references “2021 Q4,” but the supplied document is the company’s FY2022 annual Form 10-K, not a quarterly filing.
Business context
Kulicke & Soffa designs, manufactures and sells semiconductor assembly equipment, bonding tools, aftermarket products and services. Its customers include integrated device manufacturers, outsourced semiconductor assembly and test providers, electronics manufacturers and automotive suppliers. The company reports two segments: Capital Equipment and Aftermarket Products and Services (APS).
- Approximately 94.4% of FY2022 revenue was shipped to customers outside the United States.
- China represented approximately 56.9% of FY2022 revenue, compared with 55.6% in FY2021.
- No customer exceeded 10% of FY2022 revenue; the ten largest customers represented 49.1% of revenue, down from 62.0% in FY2021.
Financial performance and key metrics
| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Net revenue | $1,503.6 million | $1,517.7 million | Down 0.9% |
| Gross profit | $748.3 million | $697.0 million | Up 7.4% |
| Gross margin | 49.8% | 45.9% | Up 390 basis points |
| Income from operations | $470.1 million | $412.4 million | Up 14.0% |
| Operating margin | 31.3% | 27.2% | Up approximately 410 basis points |
| Net income | $433.5 million | $367.2 million | Up 18.1% |
| Diluted EPS | $7.09 | $5.78 | Up 22.7% |
| Operating cash flow | $390.2 million | $300.0 million | Up 30.0% |
- Capital Equipment revenue was $1,306.5 million, down 0.5%, while APS revenue was $197.2 million, down 3.9%.
- Capital Equipment gross margin increased to 48.2% from 44.0%; APS gross margin increased to 60.4% from 58.2%.
- Operating expense declined 2.2% to $278.2 million. SG&A declined 3.9%, partly due to a favorable $7.1 million foreign-exchange variance; R&D declined 0.5%.
- Net income benefited from higher operating income, higher interest income and a lower effective tax rate of 9.1%, compared with 11.4%.
Liquidity, cash flow and capital structure
| Metric | October 1, 2022 | October 2, 2021 |
|---|---|---|
| Cash and cash equivalents | $555.5 million | $362.8 million |
| Short-term investments | $220.0 million | $377.0 million |
| Total cash, cash equivalents and short-term investments | $775.5 million | $739.8 million |
| Total liabilities | $393.9 million | $506.4 million |
| Shareholders’ equity | $1,194.7 million | $1,095.2 million |
- Net cash provided by investing activities was $133.8 million, primarily reflecting $157.0 million of net maturities of short-term investments, partially offset by $23.0 million of capital expenditures.
- Net cash used in financing activities was $321.2 million, including $281.3 million of share repurchases and $39.4 million of dividends paid.
- There were no borrowings outstanding under the $150.0 million unsecured overdraft facility at year-end. A separate bank-guarantee facility had $2.9 million outstanding.
- Net inventory increased to $185.0 million from $167.3 million, while inventory reserves declined to $19.2 million from $23.0 million.
- Fiscal 2023 capital expenditures were expected to be approximately $70.0 million to $74.0 million.
Material changes versus the prior comparable period
- Revenue declined modestly because of lower volume in both segments. Capital Equipment demand was affected by customer investment uncertainty, while APS volume reflected lower customer utilization.
- Profitability improved substantially because of favorable product mix and pricing in Capital Equipment, favorable APS mix, lower operating expenses and higher interest income.
- Bookings fell to $1,226.5 million from $2,177.0 million, and backlog declined to $510.1 million from $787.2 million. Most orders may be canceled or deferred with limited or no penalties.
- Cash generation improved, but financing cash use increased materially because of share repurchases.
- The company repurchased approximately 5.6 million shares for $282.8 million in total, including 2.8 million shares under the regular program and 2.8 million shares delivered under a $150.0 million accelerated share repurchase agreement.
- The remaining share-repurchase authorization was approximately $249.2 million at October 1, 2022. Quarterly dividends were $0.17 per share, or $0.68 per share declared for FY2022.
- The company completed the development transition of $7.9 million of acquired in-process research and development into developed technology and recorded a $1.3 million impairment on a non-marketable equity investment.
Outlook, commentary, risks and unusual items
- Management expects existing cash, investments, credit facilities and operating cash flow to satisfy liquidity and capital requirements for at least the next twelve months and beyond.
- Management anticipates long-term semiconductor industry growth but expects continued short-term volatility, limited demand visibility and cyclical seasonality.
- COVID-19, supply-chain constraints, component shortages, freight and labor costs, inflation, rising interest rates, geopolitical tensions and the Ukraine/Russia conflict remain key uncertainties. The Ukraine/Russia conflict did not materially affect FY2022 results.
- Trade restrictions and expanded U.S. export controls affect certain advanced packaging products and may constrain sales to Huawei and other Entity List companies. The filing states that these controls had not materially affected results directly through FY2022.
- Potential Taiwan-China instability could disrupt customers, suppliers and the company’s China manufacturing operations.
- The Singapore tax incentive is scheduled to expire in fiscal 2025. Loss of the incentive could materially increase future taxes; management states that the standard Singapore tax rate would otherwise be 17%.
- Contractual and contingent obligations included $316.1 million of inventory purchase commitments, $54.4 million of U.S. transition-tax payable and $9.6 million of uncalled private-equity fund commitments.
- The company had $16.9 million of unrecognized tax benefits, including accrued interest of approximately $2.0 million. The filing does not provide a clear estimate of the timing or ultimate resolution of related tax examinations.
- The company signed an agreement to acquire Advanced Jet Automation and specified dispensing assets from an affiliate. Closing was expected in FY2023, subject to customary conditions and regulatory approvals.
- PricewaterhouseCoopers issued unqualified opinions on the financial statements and internal control over financial reporting. The critical audit matter concerned inventory reserves for excess and obsolete raw materials.
Important facts for investors to verify
- Verify the decline in bookings and backlog and assess how much of the backlog remains cancellable or deferrable.
- Assess whether the FY2022 margin expansion is sustainable or primarily reflects product mix, pricing and temporary cost effects.
- Monitor China exposure, export controls, Taiwan-China tensions and the effect of customer concentration on future revenue.
- Evaluate inventory growth, inventory reserves and the risk of write-downs if semiconductor demand weakens.
- Track the expiration or renewal of the Singapore tax incentive and the resulting potential change in the effective tax rate after fiscal 2025.
- Review the pace and valuation of remaining share repurchases relative to cash needs, planned capital expenditures and potential acquisitions.
- Confirm the closing, purchase price and integration risks associated with the planned Advanced Jet Automation transaction.